Best Practices for Dealing with Growing Threats to Information Security in Clinical Trials

Clinical Trials, Healthcare, Life Sciences,
  • Monday, June 10, 2019 | 1pm EDT (10am PDT)
  • 60 min

The digitization of operations across all industries has unlocked unprecedented efficiency, simplifying processes and increasing convenience for businesses and consumers alike. But it has also introduced a new type of vulnerability in the form of information security threats.

This shift extends to (and is arguably particularly acute in) the healthcare and clinical research spaces. With intellectual property, massive corporate investment and patients’ personal health information on the line — all centered around research that the global public depends upon to fight disease and save lives — information security in healthcare could not be more important. Organizations that hope to streamline and accelerate their processes must invest in a calculated information security plan. They must also ensure that the contemporary technology solutions they partner with have their own robust information security apparatus in place.

This webinar will dive deep into the information security landscape today and provide crucial insight into how organizations in the healthcare space can protect against breaches and keep their operations in the clear and running smoothly.



Jeremiah Grossman, Founder & CEO of Bit Discovery, Chief of Security Strategy (SentinelOne), Professional Hacker, Black Belt in Brazilian Jiu-Jitsu, and Founder of WhiteHat Security

Jeremiah Grossman’s career spans nearly 20 years and has lived a literal lifetime in computer security to become one of the industry’s biggest names. He has received a number of industry awards and has been publicly thanked by Microsoft, Mozilla, Google, Facebook and many others for his security research. Jeremiah has written hundreds of articles and white papers. As an industry veteran, he has been featured in hundreds of media outlets around the world. Jeremiah has been a guest speaker on six continents at hundreds of events including many top universities.

Message Presenter

Gabriel Gumbs, VP of Product Management, Spirion

Bio coming soon…

Message Presenter

Johannes Hoech, VP of Marketing and International Operations, Medrio

Johannes Hoech brings years of executive experience in marketing and other areas to his role at Medrio. Having served in permanent and interim executive management roles at organizations ranging in size from three people to several hundred, Johannes is an expert at driving revenue and scaling fast-growing organizations of all sizes. He approaches his work with a combined analytical and creative mentality, executing efficiently while innovating pragmatic solutions. Johannes holds an MBA in Business Management from the Sloan School of Management at MIT, and a Masters of Engineering in Naval Architecture from UC Berkeley.

Message Presenter

Who Should Attend?

Organization types:

  • CROs
  • Early-phase pharma
  • Medical device
  • Diagnostics


  • Data managers
  • Clinical trial site managers
  • ClinOps professionals
  • IT personnel


What You Will Learn

Participants will gain insights into: 

  • Where cyberattackers come from, what methods they use and what data they’re after
  • Why personal health information is often at higher risk than financial information, particularly in healthcare and clinical research
  • How life science organizations can leverage cutting-edge technology, such as artificial intelligence and blockchain, to protect against attacks
  • Why outsourcing IT infrastructure to third parties is another common method of protection

Xtalks Partner


Medrio is the leading provider of eClinical technology for early-phase pharma, device, and diagnostics clinical trials. Founded in 2005, the company’s cloud-based EDC, eSource, eConsent, and ePRO solutions deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient-reported outcome responses. Study sponsors and contract research organizations have used Medrio extensively in clinical trials across a wide array of therapeutic areas, with notable success in oncology, infectious disease, and more.  Medrio has extensive experience in all study phases and leads the market in early-phase trials.  The company serves over 500 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations.  For more information, please visit

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account